Business Summary

Prima Biomed, through its subsidiaries, is engaged in the research and commercialization of licensed medical biotechnology. The Company develops anti-cancer therapeutics based on immunotherapy. The Company's products include CVac™ which is an ovarian cancer vaccine; and cancer antibody antigen Cripto-1 which is a protein found in high levels on the surface of many different kinds of cancer cells and is also found in the blood stream of cancer patients. The Company is also developing a technology enabling oral administration of vaccines that are injected.

Data provided by Mergent, Inc.

Corporate Actions / Book Closed Notices

Recent Company News

Powered by Interactive Data Managed Solutions

Recent / Upcoming DR Events

Data provided by Thomson Reuters, Inc.
DR Symbol PBMD
CUSIP 74154B203
DR Exchange NASDAQ Stock Market
DR ISIN US74154B2034
Ratio 1:30
Depositary BK (Sponsored)
Effective Date Apr 16, 2012
Underlying ISIN AU000000PRR9
Underlying SEDOL 6350516
Country Australia
Industry HealthCareEquip.&Ser

Powered by Interactive Data Managed Solutions

Monthly DR Trading Summary

Month Month End
DR Close
Price		 DR Trading Volume Avg Day DR
Trading
Volume
Apr. 13 2.74 90,858 4,130
Mar. 13 3.21 25,717 1,354
Feb. 13 3.65 37,232 2,190
Data provided by Interactive Data Corp.

This DR is a Constituent of the following BNY Mellon DR Indices:

ADR Index

DR Index

Classic ADR Index

Related links

Custodians / BIC

Helpful Links
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

© 2013 The Bank of New York Mellon Corporation. Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Quotes delayed at least 15 minutes.Market data provided by Interactive Data
Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Certain information included in this website is proprietary to Mergent, Inc. (Mergent) Copyright © 2003-2010. Reproduction of such information in any form is prohibited. Because of the possibility of
human or mechanical error by Mergent's sources, Mergent or others, Mergent does not guarantee the accuracy, adequacy, completeness, timeliness or availability or for the results obtained from the
use of such information. Mergent Terms of Use apply

Holdings information provided by FactSet Research Systems Inc. Copyright © 2003-2013 FactSet Research Systems Inc. All rights reserved.

DR Calendar provided by Thomson Reuters, Inc. © 2013 The Thomson Reuters Corporation. All Rights Reserved. Terms of Use. Privacy Statement.
Send questions, comments or suggestions to corporateservices@thomsonreuters.com